Insys Therapeutics, Inc. Insider Trading for March 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Insys Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Insys Therapeutics, Inc. for March 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 18 2014 | INSY | Insys Therapeutics ... | Babich Michael L | President and CEO | Option Exercise | D | 4.88 | 33,124 | 161,645 | 65,356 | |
| Mar 18 2014 | INSY | Insys Therapeutics ... | Babich Michael L | President and CEO | Option Exercise | D | 1.83 | 56,876 | 104,083 | 0 | |
| Mar 18 2014 | INSY | Insys Therapeutics ... | Babich Michael L | President and CEO | Buy | M | 4.88 | 33,124 | 161,645 | 95,375 | 62.3 K to 95.4 K (+53.21 %) |
| Mar 18 2014 | INSY | Insys Therapeutics ... | Babich Michael L | President and CEO | Buy | M | 1.83 | 56,876 | 104,083 | 62,251 | 5.4 K to 62.3 K (+1,058.16 %) |
| Mar 17 2014 | INSY | Insys Therapeutics ... | KAPOOR JOHN N | Director | Gift | G | 0.00 | 190 | 0 | 14,083,204 | 14.1 M to 14.1 M (0.00 %) |
| Mar 13 2014 | INSY | Insys Therapeutics ... | STANLEY THEODORE H | Director | Buy | P | 70.75 | 100 | 7,075 | 1,400 | 1.3 K to 1.4 K (+7.69 %) |
| Mar 13 2014 | INSY | Insys Therapeutics ... | STANLEY THEODORE H | Director | Buy | P | 72.20 | 100 | 7,220 | 1,300 | 1.2 K to 1.3 K (+8.33 %) |
| Mar 13 2014 | INSY | Insys Therapeutics ... | STANLEY THEODORE H | Director | Buy | P | 72.90 | 100 | 7,290 | 1,200 | 1.1 K to 1.2 K (+9.09 %) |
| Mar 13 2014 | INSY | Insys Therapeutics ... | STANLEY THEODORE H | Director | Buy | P | 73.30 | 100 | 7,330 | 1,100 | 1,000 to 1.1 K (+10.00 %) |
| Mar 13 2014 | INSY | Insys Therapeutics ... | STANLEY THEODORE H | Director | Buy | P | 73.50 | 100 | 7,350 | 1,000 | 900 to 1,000 (+11.11 %) |
| Mar 06 2014 | INSY | Insys Therapeutics ... | STANLEY THEODORE H | Director | Buy | P | 73.80 | 100 | 7,380 | 900 | 800 to 900 (+12.50 %) |
| Mar 06 2014 | INSY | Insys Therapeutics ... | STANLEY THEODORE H | Director | Buy | P | 74.73 | 100 | 7,473 | 800 | 700 to 800 (+14.29 %) |
| Mar 06 2014 | INSY | Insys Therapeutics ... | STANLEY THEODORE H | Director | Buy | P | 76.99 | 100 | 7,699 | 700 | 600 to 700 (+16.67 %) |
| Mar 06 2014 | INSY | Insys Therapeutics ... | STANLEY THEODORE H | Director | Buy | P | 77.60 | 100 | 7,760 | 600 | 500 to 600 (+20.00 %) |
| Mar 06 2014 | INSY | Insys Therapeutics ... | Dillaha Larry | Chief Medical Offic ... | Option Exercise | D | 1.83 | 112,126 | 205,191 | 0 | |
| Mar 06 2014 | INSY | Insys Therapeutics ... | Dillaha Larry | Chief Medical Offic ... | Option Exercise | D | 3.54 | 19,056 | 67,458 | 29,944 | |
| Mar 06 2014 | INSY | Insys Therapeutics ... | Dillaha Larry | Chief Medical Offic ... | Option Exercise | D | 10.89 | 18,750 | 204,188 | 81,250 | |
| Mar 06 2014 | INSY | Insys Therapeutics ... | Dillaha Larry | Chief Medical Offic ... | Sell | S | 76.25 | 15,954 | 1,216,493 | 3,125 | 19.1 K to 3.1 K (-83.62 %) |
| Mar 06 2014 | INSY | Insys Therapeutics ... | Dillaha Larry | Chief Medical Offic ... | Sell | S | 77.24 | 17,863 | 1,379,738 | 19,079 | 36.9 K to 19.1 K (-48.35 %) |
| Mar 06 2014 | INSY | Insys Therapeutics ... | Dillaha Larry | Chief Medical Offic ... | Sell | S | 78.59 | 2,304 | 181,071 | 36,942 | 39.2 K to 36.9 K (-5.87 %) |
| Mar 06 2014 | INSY | Insys Therapeutics ... | Dillaha Larry | Chief Medical Offic ... | Sell | S | 79.81 | 3,811 | 304,156 | 39,246 | 43.1 K to 39.2 K (-8.85 %) |
| Mar 06 2014 | INSY | Insys Therapeutics ... | Dillaha Larry | Chief Medical Offic ... | Sell | S | 80.25 | 5,717 | 458,789 | 43,057 | 48.8 K to 43.1 K (-11.72 %) |
| Mar 06 2014 | INSY | Insys Therapeutics ... | Dillaha Larry | Chief Medical Offic ... | Sell | S | 81.91 | 4,680 | 383,339 | 48,774 | 53.5 K to 48.8 K (-8.76 %) |
| Mar 06 2014 | INSY | Insys Therapeutics ... | Dillaha Larry | Chief Medical Offic ... | Sell | S | 82.55 | 624 | 51,511 | 53,454 | 54.1 K to 53.5 K (-1.15 %) |
| Mar 06 2014 | INSY | Insys Therapeutics ... | Dillaha Larry | Chief Medical Offic ... | Sell | S | 83.92 | 653 | 54,800 | 54,078 | 54.7 K to 54.1 K (-1.19 %) |
| Mar 06 2014 | INSY | Insys Therapeutics ... | Dillaha Larry | Chief Medical Offic ... | Sell | S | 84.72 | 537 | 45,495 | 54,731 | 55.3 K to 54.7 K (-0.97 %) |
| Mar 06 2014 | INSY | Insys Therapeutics ... | Dillaha Larry | Chief Medical Offic ... | Sell | S | 72.65 | 97,789 | 7,104,371 | 55,268 | 153.1 K to 55.3 K (-63.89 %) |
| Mar 06 2014 | INSY | Insys Therapeutics ... | Dillaha Larry | Chief Medical Offic ... | Buy | M | 1.83 | 112,126 | 205,191 | 153,057 | 40.9 K to 153.1 K (+273.94 %) |
| Mar 06 2014 | INSY | Insys Therapeutics ... | Dillaha Larry | Chief Medical Offic ... | Buy | M | 3.54 | 19,056 | 67,458 | 40,931 | 21.9 K to 40.9 K (+87.11 %) |
| Mar 06 2014 | INSY | Insys Therapeutics ... | Dillaha Larry | Chief Medical Offic ... | Buy | M | 10.89 | 18,750 | 204,188 | 21,875 | 3.1 K to 21.9 K (+600.00 %) |
| Mar 06 2014 | INSY | Insys Therapeutics ... | Babich Michael L | President and CEO | Option Exercise | D | 1.83 | 210,958 | 386,053 | 56,876 | |
| Mar 06 2014 | INSY | Insys Therapeutics ... | Babich Michael L | President and CEO | Option Exercise | D | 3.54 | 1,167 | 4,131 | 175,833 | |
| Mar 06 2014 | INSY | Insys Therapeutics ... | Babich Michael L | President and CEO | Sell | S | 76.25 | 30,969 | 2,361,386 | 5,375 | 36.3 K to 5.4 K (-85.21 %) |
| Mar 06 2014 | INSY | Insys Therapeutics ... | Babich Michael L | President and CEO | Sell | S | 77.24 | 34,676 | 2,678,374 | 36,344 | 71 K to 36.3 K (-48.83 %) |
| Mar 06 2014 | INSY | Insys Therapeutics ... | Babich Michael L | President and CEO | Sell | S | 78.59 | 4,473 | 351,533 | 71,020 | 75.5 K to 71 K (-5.93 %) |
| Mar 06 2014 | INSY | Insys Therapeutics ... | Babich Michael L | President and CEO | Sell | S | 79.81 | 7,398 | 590,434 | 75,493 | 82.9 K to 75.5 K (-8.92 %) |
| Mar 06 2014 | INSY | Insys Therapeutics ... | Babich Michael L | President and CEO | Sell | S | 80.25 | 11,099 | 890,695 | 82,891 | 94 K to 82.9 K (-11.81 %) |
| Mar 06 2014 | INSY | Insys Therapeutics ... | Babich Michael L | President and CEO | Sell | S | 81.91 | 9,085 | 744,152 | 93,990 | 103.1 K to 94 K (-8.81 %) |
| Mar 06 2014 | INSY | Insys Therapeutics ... | Babich Michael L | President and CEO | Sell | S | 82.55 | 1,211 | 99,968 | 103,075 | 104.3 K to 103.1 K (-1.16 %) |
| Mar 06 2014 | INSY | Insys Therapeutics ... | Babich Michael L | President and CEO | Sell | S | 83.92 | 1,267 | 106,327 | 104,286 | 105.6 K to 104.3 K (-1.20 %) |
| Mar 06 2014 | INSY | Insys Therapeutics ... | Babich Michael L | President and CEO | Sell | S | 84.72 | 1,043 | 88,363 | 105,553 | 106.6 K to 105.6 K (-0.98 %) |
| Mar 06 2014 | INSY | Insys Therapeutics ... | Babich Michael L | President and CEO | Sell | S | 72.65 | 187,211 | 13,600,879 | 106,596 | 293.8 K to 106.6 K (-63.72 %) |
| Mar 06 2014 | INSY | Insys Therapeutics ... | Babich Michael L | President and CEO | Buy | M | 1.83 | 210,958 | 386,053 | 293,807 | 82.8 K to 293.8 K (+254.63 %) |
| Mar 06 2014 | INSY | Insys Therapeutics ... | Babich Michael L | President and CEO | Buy | M | 3.54 | 1,167 | 4,131 | 82,849 | 81.7 K to 82.8 K (+1.43 %) |